- Home
- BA vs PFE Comparison
BA vs PFE Comparison
Compare BA & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BA
- PFE
- Stock Information
- Founded
- BA 1916
- PFE 1849
- Country
- BA United States
- PFE United States
- Employees
- BA N/A
- PFE N/A
- Industry
- BA Aerospace
- PFE Biotechnology: Pharmaceutical Preparations
- Sector
- BA Industrials
- PFE Health Care
- Exchange
- BA Nasdaq
- PFE Nasdaq
- Market Cap
- BA 132.3B
- PFE 149.7B
- IPO Year
- BA N/A
- PFE N/A
- Fundamental
- Price
- BA $179.11
- PFE $26.16
- Analyst Decision
- BA Buy
- PFE Buy
- Analyst Count
- BA 21
- PFE 13
- Target Price
- BA $200.68
- PFE $32.17
- AVG Volume (30 Days)
- BA 8.0M
- PFE 37.5M
- Earning Date
- BA 01-28-2025
- PFE 02-04-2025
- Dividend Yield
- BA N/A
- PFE 6.65%
- EPS Growth
- BA N/A
- PFE 284.33
- EPS
- BA N/A
- PFE 1.41
- Revenue
- BA $66,517,000,000.00
- PFE $63,627,000,000.00
- Revenue This Year
- BA $31.55
- PFE $8.73
- Revenue Next Year
- BA $15.70
- PFE $0.10
- P/E Ratio
- BA N/A
- PFE $18.32
- Revenue Growth
- BA N/A
- PFE 8.77
- 52 Week Low
- BA $137.03
- PFE $24.48
- 52 Week High
- BA $213.77
- PFE $31.54
- Technical
- Relative Strength Index (RSI)
- BA 59.20
- PFE 46.74
- Support Level
- BA $173.13
- PFE $25.60
- Resistance Level
- BA $181.78
- PFE $26.92
- Average True Range (ATR)
- BA 5.68
- PFE 0.54
- MACD
- BA -0.00
- PFE -0.06
- Stochastic Oscillator
- BA 57.23
- PFE 37.76
About BA Boeing Company (The)
Boeing is a major aerospace and defense firm. It operates in three segments: commercial airplanes; defense, space, and security; and global services. Boeing's commercial airplanes segment competes with Airbus in the production of aircraft that can carry more than 130 passengers. Boeing's defense, space, and security segment competes with defense contractors such as Lockheed and Northrop to create military aircraft, satellites, and weaponry. Global services provides aftermarket support to airlines.
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.